colorectal cancer. Malignant neoplasm of colon
Conditions
Interventions
Intervention 1: Intervention group: Patients randomly enter the intervention group, and use 5 ml of the prescribed extract for 7 days from the second day of chemotherapy until the seventh course of ch
Sponsors
Yazd University of Medical Sciences
Eligibility
Sex/Gender
All
Age
20 Years to 80 Years
Inclusion criteria
Inclusion criteria: Patients with Colorectal Cancer aged between 20 and 80 years old receiving the FOLFOX chemotherapy regimen
Exclusion criteria
Exclusion criteria: patients with a history of other types of cancers history of receiving chemotherapy history of seizure and drug use anticonvulsants previous neuropathy having allergies and allergic to each of the components studied
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| . Peripheral neuropathy. Timepoint: End of day 7 after each chemotherapy course until the seventh term of chemotherapy. Method of measurement: questionnaire. | — |
Secondary
| Measure | Time frame |
|---|---|
| The sensitivity touching cold. Timepoint: End of day 7 after each chemotherapy course until the seventh term of chemotherapy. Method of measurement: questionnaire.;Hyperalgesia. Timepoint: End of day 7 after each chemotherapy course until the seventh term of chemotherapy. Method of measurement: questionnaire.;Experiencing tingling in hands or feet. Timepoint: End of day 7 after each chemotherapy course until the seventh term of chemotherapy. Method of measurement: questionnaire. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactAlimohamad Ranjbar Jamal abadi
Yazd University of Medical Sciences
Outcome results
None listed